Table 3.
Rates of ECMO complications
| All patients | Influenza | COVID‐19 | ||
|---|---|---|---|---|
| Number of patients | n = 45 | n = 17 | n = 28 | p Value |
| Length on ECMO (days) | 17.8 ± 16.1 | 12.2 ± 5.7 | 21.4 ± 19.4 | .025 |
| ECMO survival | 35 (78%) | 16 (94%) | 19 (68%) | .040 |
| 30 Days after decannulation survival | 28 (62%) | 13 (76%) | 15 (54%) | .130 |
| Complications | ||||
| Renal failure | 10 (22%) | 3 (18%) | 7 (25%) | .565 |
| Liver failure | 3 (7%) | 1 (6%) | 2 (7%) | .869 |
| Stroke | 2 (4%) | 1 (6%) | 1 (4%) | .715 |
| Brain bleed | 2 (4%) | 1 (6%) | 1 (4%) | .715 |
| Cannula site bleed | 5 (11%) | 1 (6%) | 4 (14%) | .384 |
| GI bleed | 9 (20%) | 3 (18%) | 6 (21%) | .758 |
| Any new infection during ECMO | 17 (38%) | 3 (18%) | 14 (50%) | .030 |
| Bacterial pneumonia | 11 (24%) | 1 (6%) | 10 (36%) | .024 |
| Blood culture‐positive sepsis | 10 (22%) | 1 (6%) | 9 (32%) | .040 |
Note: Data are expressed with number (percentage).
Abbreviations: COVID‐19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; GI, gastrointestinal.